Blue Trust Inc. Has $34,000 Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Blue Trust Inc. lifted its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 242.9% during the 3rd quarter, Holdings Channel.com reports. The firm owned 24 shares of the medical instruments supplier’s stock after purchasing an additional 17 shares during the quarter. Blue Trust Inc.’s holdings in Mettler-Toledo International were worth $34,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Family Firm Inc. bought a new position in shares of Mettler-Toledo International during the 2nd quarter worth approximately $25,000. Rothschild Investment LLC bought a new position in shares of Mettler-Toledo International during the 2nd quarter worth approximately $42,000. Itau Unibanco Holding S.A. bought a new position in shares of Mettler-Toledo International during the 2nd quarter worth approximately $42,000. Crewe Advisors LLC lifted its position in shares of Mettler-Toledo International by 244.4% during the 2nd quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 22 shares during the period. Finally, Bellevue Group AG lifted its position in shares of Mettler-Toledo International by 32.0% during the 1st quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock worth $44,000 after buying an additional 8 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,342.09 on Friday. The stock has a fifty day moving average of $1,403.38 and a 200-day moving average of $1,395.42. The stock has a market capitalization of $28.48 billion, a P/E ratio of 36.93, a price-to-earnings-growth ratio of 3.78 and a beta of 1.16. Mettler-Toledo International Inc. has a 52 week low of $953.28 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating the consensus estimate of $9.00 by $0.65. The company had revenue of $946.75 million during the quarter, compared to analysts’ expectations of $929.13 million. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The business’s revenue for the quarter was down 3.6% on a year-over-year basis. During the same period last year, the firm earned $10.19 EPS. Equities research analysts forecast that Mettler-Toledo International Inc. will post 40.34 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $6,884,514. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. JPMorgan Chase & Co. raised their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. The Goldman Sachs Group raised their target price on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 9th. Stifel Nicolaus lifted their price objective on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research report on Monday, August 5th. StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. Finally, Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and a consensus price target of $1,363.75.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.